Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01545479Phase 4Completed
Phase 4, open-label, single-arm trial of captopril in kidney disease, sponsored by Instituto de Cardiologia do Rio Grande do Sul. Primary endpoint: Renal blood oxygenation at 30 minutes. Started Jan 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01545479.